首页>
外国专利>
Treatment regimen utilizing neratinib for breast cancer
Treatment regimen utilizing neratinib for breast cancer
展开▼
机译:使用neratinib治疗乳腺癌的治疗方案
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention provides neratinib for use in a method for treating early stage HER-2 positive breast cancer, wherein the method comprises delivering neratinib therapy to early stage HER-2 positive breast cancer patients at the completion of at least twelve months of trastuzumab adjuvant therapy; wherein the neratinib therapy is started about 2 weeks to about one year from the completion of surgical and standard adjuvant therapy.
展开▼